Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06512376

Hereditary Cerebral Small Vessel Diseases Registry-Trial Ready Cohort

Hereditary Cerebral Small Vessel Diseases Registry-Trial Ready Cohort (HCSVD-TRC)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

We took hereditary cerebral small vessel disease (hCSVD) patients as our main subjects, aiming to establish a platform for a comprehensive evaluation and long-term follow-up. Deeply explore the pathophysiological mechanism of hCSVD, which may render the theoretical basis for the treatment and management of hCSVD.

Detailed description

Cerebral Small Vessel Disease is a series of clinical, imaging, and pathological syndromes caused by a variety of risk factors affecting cerebral arterioles, arterioles, capillaries, and venules, accounting for 20% of stroke and 45% of dementia. Although the incidence rate of hereditary small cerebral vascular disease is low, because of its early onset, high disability rate, and lack of effective treatment, it also brings a heavy burden to the patients and their families. Therefore, it is important to study the pathogenic gene, pathogenesis, clinical characteristics, and imaging manifestations of hereditary cerebrovascular disease to provide a theoretical basis for the treatment and prevention of hereditary cerebrovascular disease in the future. This multi-center, prospective, continuous, registry study, runs from 2022 to 2027. The study is expected to recruit 100 subjects, according to the sample size design of the registry study. We recruited patients with the hereditary cerebral small-vessel disease (hCSVD) intending to establish a platform for a comprehensive assessment and long-term follow-up by collecting genetics, imaging, and clinical symptoms of the primary disease and its relatives. With long-term follow-up of the development and prognosis of imaging and clinical symptoms combined with genetics, we will work on the correlation between genes and phenotype and deeply explore the pathophysiological mechanism of hCSVD, which may render the theoretical basis for the treatment and management of hCSVD.

Conditions

Timeline

Start date
2022-07-19
Primary completion
2027-07-19
Completion
2027-07-19
First posted
2024-07-22
Last updated
2024-07-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06512376. Inclusion in this directory is not an endorsement.